can you please make me a detailed presentation on the topic recent advances in management of varicose veins

Reading File
Reading File
Reading File
Finding Sources
Searching PubMed

"varicose veins" AND management

Searching the Web

recent advances management varicose veins 2024 2025 treatment guidelines

Reading File
Reading File
Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC12462076

Reading Article

PMID: 37652254

Reading File
Reading File
Running Command

mkdir -p /home/daytona/workspace/varicose-veins-ppt && ls /home/daytona/workspac…

Writing File

~/varicose-veins-ppt/create_pptx.js

const pptxgen = require("pptxgenjs");

const pres = new pptxgen();
pres.layout = "LAYOUT_16x9";
pres.author = "Medical Education";
pres.title = "Recent Advances in Management of Varicose Veins";

// ─── COLOR PALETTE ───────────────────────────────────────────────
const DARK_BG    = "0D1B2A";   // deep navy
const MID_BG     = "1B3A5C";   // medium blue
const ACCENT1    = "4FC3F7";   // sky blue
const ACCENT2    = "00BFA5";   // teal
const ACCENT3    = "FF7043";   // warm orange
const WHITE      = "FFFFFF";
const LIGHT_GRAY = "E8F4FD";
const TEXT_DARK  = "1A2E40";
const SUBTITLE   = "B0C4DE";
const BOX_BG     = "132538";

// ─── HELPER: section header bar ──────────────────────────────────
function addSectionBar(slide, label, color) {
  slide.addShape(pres.ShapeType.rect, {
    x: 0, y: 0, w: 10, h: 0.65,
    fill: { color: color || MID_BG },
    line: { color: color || MID_BG }
  });
  slide.addText(label, {
    x: 0.3, y: 0, w: 9.4, h: 0.65,
    fontSize: 13, bold: true, color: WHITE, valign: "middle", margin: 0
  });
}

function addBottomBar(slide) {
  slide.addShape(pres.ShapeType.rect, {
    x: 0, y: 5.3, w: 10, h: 0.325,
    fill: { color: DARK_BG }, line: { color: DARK_BG }
  });
  slide.addText("Recent Advances in Management of Varicose Veins", {
    x: 0.2, y: 5.3, w: 9.6, h: 0.325,
    fontSize: 8, color: SUBTITLE, valign: "middle", margin: 0
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 1 — TITLE
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };

  // decorative top stripe
  s.addShape(pres.ShapeType.rect, { x: 0, y: 0, w: 10, h: 0.18, fill: { color: ACCENT1 }, line: { color: ACCENT1 } });
  // accent left bar
  s.addShape(pres.ShapeType.rect, { x: 0, y: 0.18, w: 0.08, h: 5.445, fill: { color: ACCENT2 }, line: { color: ACCENT2 } });

  s.addText("RECENT ADVANCES IN", {
    x: 0.3, y: 0.8, w: 9.4, h: 0.6,
    fontSize: 22, bold: true, color: ACCENT1, align: "center",
    charSpacing: 4
  });
  s.addText("Management of\nVaricose Veins", {
    x: 0.3, y: 1.4, w: 9.4, h: 1.6,
    fontSize: 42, bold: true, color: WHITE, align: "center"
  });
  s.addShape(pres.ShapeType.rect, { x: 2.5, y: 3.05, w: 5, h: 0.06, fill: { color: ACCENT2 }, line: { color: ACCENT2 } });
  s.addText("Evidence-Based Approaches  |  Minimally Invasive Techniques  |  2025 Guidelines", {
    x: 0.5, y: 3.2, w: 9, h: 0.45,
    fontSize: 13, color: SUBTITLE, align: "center", italic: true
  });
  s.addText("Based on SVS/AVF/AVLS 2023-24 Guidelines • 2025 SCAI Guidelines • Bailey & Love 28th Ed. • Schwartz's Surgery 11th Ed.", {
    x: 0.5, y: 4.9, w: 9, h: 0.4,
    fontSize: 9, color: SUBTITLE, align: "center"
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 2 — TABLE OF CONTENTS
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "OVERVIEW", MID_BG);
  addBottomBar(s);

  s.addText("Presentation Outline", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55,
    fontSize: 26, bold: true, color: WHITE
  });

  const topics = [
    ["01", "Epidemiology & Classification (CEAP)", ACCENT1],
    ["02", "Pathophysiology & Risk Factors", ACCENT2],
    ["03", "Diagnosis: Duplex Ultrasound & Imaging", ACCENT1],
    ["04", "Conservative Management", ACCENT2],
    ["05", "Endovenous Thermal Ablation (EVLA & RFA)", ACCENT1],
    ["06", "Non-Thermal, Non-Tumescent (NTNT) Techniques", ACCENT2],
    ["07", "Sclerotherapy: Foam & VeinGogh", ACCENT1],
    ["08", "Surgical Approaches & Phlebectomy", ACCENT2],
    ["09", "2023-2025 Clinical Practice Guidelines", ACCENT1],
    ["10", "Emerging Technologies & Future Directions", ACCENT2],
  ];

  topics.forEach(([num, text, col], i) => {
    const col2 = i < 5 ? 0.35 : 5.15;
    const row = i < 5 ? i : i - 5;
    const y = 1.45 + row * 0.7;
    s.addShape(pres.ShapeType.rect, {
      x: col2, y, w: 0.48, h: 0.48,
      fill: { color: col }, line: { color: col }
    });
    s.addText(num, {
      x: col2, y, w: 0.48, h: 0.48,
      fontSize: 14, bold: true, color: DARK_BG, align: "center", valign: "middle", margin: 0
    });
    s.addText(text, {
      x: col2 + 0.55, y: y + 0.05, w: 4.2, h: 0.38,
      fontSize: 11.5, color: WHITE, valign: "middle", margin: 0
    });
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 3 — EPIDEMIOLOGY & CEAP
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "01  |  EPIDEMIOLOGY & CLASSIFICATION", ACCENT1.replace("4FC3F7","2a7fa8") && "1B6CA8");
  addBottomBar(s);

  s.addText("Epidemiology & CEAP Classification", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 24, bold: true, color: WHITE
  });

  // Epi box
  s.addShape(pres.ShapeType.rect, { x: 0.3, y: 1.4, w: 4.3, h: 3.7, fill: { color: BOX_BG }, line: { color: ACCENT1, width: 1.5 } });
  s.addText("Epidemiology", { x: 0.3, y: 1.4, w: 4.3, h: 0.45, fontSize: 13, bold: true, color: ACCENT1, align: "center", valign: "middle", margin: 0 });
  s.addText([
    { text: "• 30-50% ", options: { bold: true, color: ACCENT2 } },
    { text: "adult prevalence of visible varicose veins\n", options: { color: WHITE } },
    { text: "• More common in women; rises sharply with age\n", options: { color: WHITE } },
    { text: "• Edinburgh Vein Study: ", options: { bold: true, color: ACCENT1 } },
    { text: "55.7% prevalence in 55-64 yr age group\n", options: { color: WHITE } },
    { text: "• Risk factors: ", options: { bold: true, color: ACCENT1 } },
    { text: "obesity, pregnancy, prolonged standing, family history, female sex\n", options: { color: WHITE } },
    { text: "• Venous disease causes ", options: { color: WHITE } },
    { text: "~85% ", options: { bold: true, color: ACCENT2 } },
    { text: "of all chronic lower limb ulcers\n", options: { color: WHITE } },
    { text: "• Dressings for venous ulcers = ", options: { color: WHITE } },
    { text: "1-3% of western healthcare spend", options: { bold: true, color: ACCENT3 } },
  ], { x: 0.45, y: 1.9, w: 4.0, h: 3.1, fontSize: 10.5, valign: "top" });

  // CEAP box
  s.addShape(pres.ShapeType.rect, { x: 5.0, y: 1.4, w: 4.7, h: 3.7, fill: { color: BOX_BG }, line: { color: ACCENT2, width: 1.5 } });
  s.addText("CEAP Classification", { x: 5.0, y: 1.4, w: 4.7, h: 0.45, fontSize: 13, bold: true, color: ACCENT2, align: "center", valign: "middle", margin: 0 });
  const ceap = [
    ["C0", "No visible/palpable signs"],
    ["C1", "Telangiectasias / reticular veins"],
    ["C2", "Varicose veins"],
    ["C3", "Edema"],
    ["C4a", "Pigmentation / eczema"],
    ["C4b", "Lipodermatosclerosis / atrophie blanche"],
    ["C5", "Healed venous ulcer"],
    ["C6", "Active venous ulcer"],
  ];
  ceap.forEach(([c, desc], i) => {
    s.addShape(pres.ShapeType.rect, {
      x: 5.15, y: 1.9 + i * 0.41, w: 0.55, h: 0.34,
      fill: { color: i < 3 ? "1B6CA8" : i < 6 ? "B85C00" : "7B1818" },
      line: { color: "00000000" }
    });
    s.addText(c, { x: 5.15, y: 1.9 + i * 0.41, w: 0.55, h: 0.34, fontSize: 9.5, bold: true, color: WHITE, align: "center", valign: "middle", margin: 0 });
    s.addText(desc, { x: 5.78, y: 1.9 + i * 0.41, w: 3.7, h: 0.34, fontSize: 9.5, color: WHITE, valign: "middle", margin: 0 });
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 4 — PATHOPHYSIOLOGY
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "02  |  PATHOPHYSIOLOGY & RISK FACTORS", "1B6CA8");
  addBottomBar(s);

  s.addText("Pathophysiology of Varicose Veins", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 24, bold: true, color: WHITE
  });

  const boxes = [
    { x: 0.3, y: 1.45, w: 2.9, h: 3.6, title: "Valve Failure", col: ACCENT1, pts: [
      "Valvular incompetence → retrograde blood flow",
      "Venous hypertension in superficial system",
      "GSV reflux: 60% of cases",
      "SSV reflux: 20% of cases",
    ]},
    { x: 3.35, y: 1.45, w: 2.9, h: 3.6, title: "Wall Changes", col: ACCENT2, pts: [
      "Smooth muscle hypertrophy and atrophy",
      "Altered collagen/elastin ratio",
      "MMP activation → matrix degradation",
      "Chronic inflammatory infiltrate",
    ]},
    { x: 6.4, y: 1.45, w: 3.3, h: 3.6, title: "Complications", col: ACCENT3, pts: [
      "Superficial vein thrombosis (thrombophlebitis)",
      "Lipodermatosclerosis",
      "Venous eczema / pigmentation",
      "Healed or active venous ulcer (C5/C6)",
      "Haemorrhage from attenuated veins",
    ]},
  ];

  boxes.forEach(b => {
    s.addShape(pres.ShapeType.rect, { x: b.x, y: b.y, w: b.w, h: b.h, fill: { color: BOX_BG }, line: { color: b.col, width: 1.5 } });
    s.addText(b.title, { x: b.x, y: b.y, w: b.w, h: 0.42, fontSize: 12, bold: true, color: b.col, align: "center", valign: "middle", margin: 0 });
    b.pts.forEach((pt, i) => {
      s.addText("▸  " + pt, { x: b.x + 0.12, y: b.y + 0.52 + i * 0.65, w: b.w - 0.2, h: 0.58, fontSize: 10, color: WHITE, valign: "top" });
    });
  });

  s.addText("Primary varicose veins: intrinsic wall/valve defect  |  Secondary varicose veins: post-DVT or pelvic obstruction", {
    x: 0.3, y: 5.07, w: 9.4, h: 0.25, fontSize: 9, color: SUBTITLE, align: "center"
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 5 — DIAGNOSIS
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "03  |  DIAGNOSIS: DUPLEX ULTRASOUND & IMAGING", "1B6CA8");
  addBottomBar(s);

  s.addText("Diagnosis & Assessment", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 24, bold: true, color: WHITE
  });

  // Left column
  s.addShape(pres.ShapeType.rect, { x: 0.3, y: 1.42, w: 5.5, h: 3.65, fill: { color: BOX_BG }, line: { color: ACCENT1, width: 1.5 } });
  s.addText("Duplex Ultrasound (Gold Standard)", { x: 0.3, y: 1.42, w: 5.5, h: 0.42, fontSize: 12.5, bold: true, color: ACCENT1, align: "center", valign: "middle", margin: 0 });
  s.addText([
    { text: "• Performed in standing position", options: { breakLine: true } },
    { text: "• Pneumatic cuff deflation test: reflux >0.5 sec = pathological", options: { breakLine: true } },
    { text: "• Evaluates: common femoral, femoral, popliteal, posterior tibial, GSV & SSV", options: { breakLine: true } },
    { text: "• Identifies: reflux site, perforator incompetence, deep vein obstruction", options: { breakLine: true } },
    { text: "• Essential for treatment planning and ablation guidance", options: { breakLine: true } },
    { text: "• SVS/AVF 2023 Guideline: ", options: { bold: true, color: ACCENT2, breakLine: false } },
    { text: "mandatory pre-intervention duplex in all patients", options: { breakLine: false } },
  ], { x: 0.45, y: 1.9, w: 5.2, h: 3.0, fontSize: 10.5, color: WHITE, valign: "top" });

  // Right column
  s.addShape(pres.ShapeType.rect, { x: 6.05, y: 1.42, w: 3.65, h: 3.65, fill: { color: BOX_BG }, line: { color: ACCENT2, width: 1.5 } });
  s.addText("Other Modalities", { x: 6.05, y: 1.42, w: 3.65, h: 0.42, fontSize: 12.5, bold: true, color: ACCENT2, align: "center", valign: "middle", margin: 0 });
  const modalities = [
    ["CT Venography", "Pelvic/iliac obstruction, May-Thurner syndrome"],
    ["MR Venography", "Complex anatomy, pelvic congestion syndrome"],
    ["IVUS", "Deep vein stenting planning"],
    ["Air Plethysmography", "Functional venous reserve assessment"],
    ["VeinViewer / Near-IR", "Superficial vein mapping pre-procedure"],
  ];
  modalities.forEach(([mod, desc], i) => {
    s.addText(mod, { x: 6.2, y: 1.9 + i * 0.62, w: 1.5, h: 0.5, fontSize: 9.5, bold: true, color: ACCENT1, valign: "middle", margin: 0 });
    s.addText(desc, { x: 7.72, y: 1.9 + i * 0.62, w: 1.8, h: 0.5, fontSize: 9, color: WHITE, valign: "middle", margin: 0 });
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 6 — CONSERVATIVE MANAGEMENT
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "04  |  CONSERVATIVE MANAGEMENT", "1B6CA8");
  addBottomBar(s);

  s.addText("Conservative & Medical Management", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 24, bold: true, color: WHITE
  });

  const cards = [
    {
      x: 0.3, y: 1.42, w: 2.9, h: 3.65, title: "Compression Therapy", col: ACCENT1,
      pts: [
        "First-line for all symptomatic CVD",
        "20-30 mmHg: mild symptoms",
        "30-40 mmHg: moderate-severe / ulcers",
        "40-50 mmHg: lymphoedema",
        "Knee-high to waist-high depending on distribution",
        "Unna's boot / multilayer wraps for ulcers",
        "Pneumatic compression devices for refractory cases",
      ]
    },
    {
      x: 3.4, y: 1.42, w: 2.9, h: 3.65, title: "Venoactive Drugs", col: ACCENT2,
      pts: [
        "Micronized purified flavonoid fraction (Daflon 500/1000)",
        "Reduces venous hypertension & capillary leakage",
        "Indicated for C2-C4 symptoms",
        "Horse chestnut seed extract (Escin)",
        "Calcium dobesilate: reduces capillary permeability",
        "2023 SVS/AVF: grade 1B evidence for symptom relief",
        "Adjunct - not a substitute for intervention",
      ]
    },
    {
      x: 6.5, y: 1.42, w: 3.2, h: 3.65, title: "Lifestyle & Prevention", col: ACCENT3,
      pts: [
        "Weight reduction (BMI-linked risk)",
        "Leg elevation above heart level",
        "Regular walking / calf muscle pump activation",
        "Avoid prolonged standing",
        "Anti-inflammatory diet",
        "Screen for DVT in acute thrombophlebitis",
      ]
    },
  ];

  cards.forEach(b => {
    s.addShape(pres.ShapeType.rect, { x: b.x, y: b.y, w: b.w, h: b.h, fill: { color: BOX_BG }, line: { color: b.col, width: 1.5 } });
    s.addText(b.title, { x: b.x, y: b.y, w: b.w, h: 0.42, fontSize: 11.5, bold: true, color: b.col, align: "center", valign: "middle", margin: 0 });
    b.pts.forEach((pt, i) => {
      s.addText("• " + pt, { x: b.x + 0.12, y: b.y + 0.5 + i * 0.44, w: b.w - 0.2, h: 0.42, fontSize: 9.8, color: WHITE, valign: "top" });
    });
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 7 — ENDOVENOUS THERMAL ABLATION
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "05  |  ENDOVENOUS THERMAL ABLATION", "1B6CA8");
  addBottomBar(s);

  s.addText("Endovenous Thermal Ablation (ETA)", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 24, bold: true, color: WHITE
  });

  // EVLA box
  s.addShape(pres.ShapeType.rect, { x: 0.3, y: 1.38, w: 4.5, h: 3.72, fill: { color: BOX_BG }, line: { color: ACCENT1, width: 1.8 } });
  s.addText("Endovenous Laser Ablation (EVLA)", { x: 0.3, y: 1.38, w: 4.5, h: 0.42, fontSize: 12, bold: true, color: ACCENT1, align: "center", valign: "middle", margin: 0 });
  s.addText([
    { text: "Wavelengths:\n", options: { bold: true, color: ACCENT2, breakLine: false } },
    { text: "810–1470 nm; longer wavelengths (1470 nm water-absorbing) cause less pain & bruising\n\n", options: { color: WHITE } },
    { text: "VenaCure EVLT 2.0 (2025):\n", options: { bold: true, color: ACCENT2, breakLine: false } },
    { text: "Dual-wavelength system for high-throughput ambulatory settings\n\n", options: { color: WHITE } },
    { text: "Mechanism:\n", options: { bold: true, color: ACCENT2, breakLine: false } },
    { text: "Thermal destruction of endothelium via laser energy delivered by fibre-optic catheter under tumescent anaesthesia\n\n", options: { color: WHITE } },
    { text: "Meta-analysis 2024 (PMID 38316290):\n", options: { bold: true, color: ACCENT3, breakLine: false } },
    { text: "RFA and EVLA have comparable occlusion rates; RFA has lower pain scores and fewer bruising events", options: { color: WHITE } },
  ], { x: 0.45, y: 1.85, w: 4.2, h: 3.1, fontSize: 10, color: WHITE, valign: "top" });

  // RFA box
  s.addShape(pres.ShapeType.rect, { x: 5.05, y: 1.38, w: 4.65, h: 3.72, fill: { color: BOX_BG }, line: { color: ACCENT2, width: 1.8 } });
  s.addText("Radiofrequency Ablation (RFA)", { x: 5.05, y: 1.38, w: 4.65, h: 0.42, fontSize: 12, bold: true, color: ACCENT2, align: "center", valign: "middle", margin: 0 });
  s.addText([
    { text: "ClosureFast System:\n", options: { bold: true, color: ACCENT1, breakLine: false } },
    { text: "Segmental heating catheter — 7 cm segments at 120°C for 20 sec\n\n", options: { color: WHITE } },
    { text: "ClosureFast Next-Gen (Medtronic, FDA 2024):\n", options: { bold: true, color: ACCENT1, breakLine: false } },
    { text: "Integrated impedance-feedback guidance for real-time treatment optimization\n\n", options: { color: WHITE } },
    { text: "Advantages:\n", options: { bold: true, color: ACCENT1, breakLine: false } },
    { text: "Less post-procedural pain/bruising vs EVLA; office-based; local anaesthesia\n\n", options: { color: WHITE } },
    { text: "2023 SVS/AVF Guideline (Grade 1B):\n", options: { bold: true, color: ACCENT3, breakLine: false } },
    { text: "Endovenous thermal ablation preferred over open surgery for GSV/SSV reflux", options: { color: WHITE } },
  ], { x: 5.2, y: 1.85, w: 4.3, h: 3.1, fontSize: 10, color: WHITE, valign: "top" });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 8 — NON-THERMAL NON-TUMESCENT (NTNT)
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "06  |  NON-THERMAL, NON-TUMESCENT (NTNT) TECHNIQUES", "1B6CA8");
  addBottomBar(s);

  s.addText("NTNT Ablation: The New Frontier", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 24, bold: true, color: WHITE
  });

  s.addText("Advantages over ETA: No tumescent anaesthesia • No thermal nerve damage risk • Suitable for tortuous veins • Office-based", {
    x: 0.3, y: 1.35, w: 9.4, h: 0.4, fontSize: 10.5, color: ACCENT2, align: "center", italic: true
  });

  const ntnt = [
    {
      x: 0.3, y: 1.82, w: 3.1, h: 3.3, title: "Cyanoacrylate Closure\n(VenaSeal™)", col: ACCENT1,
      pts: [
        "Medical-grade cyanoacrylate glue injected via catheter",
        "No tumescent anaesthesia needed",
        "Single access point; no compression hosiery required post-op",
        "2-year occlusion rates ~94%",
        "Risk: hypersensitivity/foreign body granuloma (~2%)",
      ]
    },
    {
      x: 3.55, y: 1.82, w: 3.1, h: 3.3, title: "Mechanochemical Ablation\n(MOCA - ClariVein®)", col: ACCENT2,
      pts: [
        "Rotating wire tip creates endothelial damage",
        "Simultaneously infuses sclerosant (polidocanol)",
        "No tumescent; low pain",
        "MARADONA trial: non-inferior to EVLA at 1 year",
        "Best for medium-diameter veins (5-12 mm)",
      ]
    },
    {
      x: 6.8, y: 1.82, w: 2.9, h: 3.3, title: "Steam Ablation\n(SVS)", col: ACCENT3,
      pts: [
        "Superheated steam (120°C) pulses delivered via catheter",
        "No tumescent required",
        "Good for small/tortuous veins inaccessible to other catheters",
        "Early studies show comparable occlusion rates",
      ]
    },
  ];

  ntnt.forEach(b => {
    s.addShape(pres.ShapeType.rect, { x: b.x, y: b.y, w: b.w, h: b.h, fill: { color: BOX_BG }, line: { color: b.col, width: 1.5 } });
    s.addText(b.title, { x: b.x, y: b.y, w: b.w, h: 0.55, fontSize: 10.5, bold: true, color: b.col, align: "center", valign: "middle", margin: 0 });
    b.pts.forEach((pt, i) => {
      s.addText("• " + pt, { x: b.x + 0.1, y: b.y + 0.62 + i * 0.5, w: b.w - 0.18, h: 0.48, fontSize: 9.5, color: WHITE, valign: "top" });
    });
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 9 — SCLEROTHERAPY
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "07  |  SCLEROTHERAPY: FOAM & ULTRASOUND-GUIDED", "1B6CA8");
  addBottomBar(s);

  s.addText("Sclerotherapy: Modern Approaches", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 24, bold: true, color: WHITE
  });

  s.addShape(pres.ShapeType.rect, { x: 0.3, y: 1.4, w: 4.5, h: 3.68, fill: { color: BOX_BG }, line: { color: ACCENT1, width: 1.5 } });
  s.addText("Foam Sclerotherapy (UGFS)", { x: 0.3, y: 1.4, w: 4.5, h: 0.42, fontSize: 12.5, bold: true, color: ACCENT1, align: "center", valign: "middle", margin: 0 });
  s.addText([
    { text: "Mechanism: ", options: { bold: true, color: ACCENT2 } },
    { text: "sclerosant destroys venous endothelium → inflammatory thrombosis → fibrosis\n\n", options: { color: WHITE } },
    { text: "Agents & concentrations:\n", options: { bold: true, color: ACCENT2 } },
    { text: "• Polidocanol 1-3% (foam)\n", options: { color: WHITE } },
    { text: "• Sodium tetradecyl sulfate 1-3% (foam)\n", options: { color: WHITE } },
    { text: "• Hypertonic saline for telangiectasias\n\n", options: { color: WHITE } },
    { text: "SCAI 2025 Guideline (Rec 4.1):\n", options: { bold: true, color: ACCENT3 } },
    { text: "Foam sclerotherapy + conservative management preferred over conservative management alone for varicose veins without truncal reflux\n\n", options: { color: WHITE } },
    { text: "Complications: ", options: { bold: true, color: ACCENT2 } },
    { text: "hyperpigmentation, thrombophlebitis, DVT, skin necrosis (rare), visual disturbance", options: { color: WHITE } },
  ], { x: 0.45, y: 1.88, w: 4.2, h: 3.08, fontSize: 9.8, color: WHITE, valign: "top" });

  s.addShape(pres.ShapeType.rect, { x: 5.05, y: 1.4, w: 4.65, h: 3.68, fill: { color: BOX_BG }, line: { color: ACCENT2, width: 1.5 } });
  s.addText("Liquid Sclerotherapy & VeinGogh", { x: 5.05, y: 1.4, w: 4.65, h: 0.42, fontSize: 12.5, bold: true, color: ACCENT2, align: "center", valign: "middle", margin: 0 });
  s.addText([
    { text: "Liquid sclerotherapy:\n", options: { bold: true, color: ACCENT1 } },
    { text: "• For telangiectasias & spider veins\n", options: { color: WHITE } },
    { text: "• Lower concentrations (0.5% polidocanol)\n", options: { color: WHITE } },
    { text: "• Compression bandaging post-injection x 3-5 days\n\n", options: { color: WHITE } },
    { text: "VeinGogh (Ohmic Thermolysis):\n", options: { bold: true, color: ACCENT1 } },
    { text: "• High-frequency microburst electrical current\n", options: { color: WHITE } },
    { text: "• Targets very fine spider veins (<1 mm)\n", options: { color: WHITE } },
    { text: "• No sclerosant agent used\n\n", options: { color: WHITE } },
    { text: "Post-procedure care:\n", options: { bold: true, color: ACCENT1 } },
    { text: "• Compression stockings minimum 2 weeks\n", options: { color: WHITE } },
    { text: "• Walking immediately encouraged\n", options: { color: WHITE } },
    { text: "• DVT prophylaxis if high-risk patient", options: { color: WHITE } },
  ], { x: 5.2, y: 1.88, w: 4.3, h: 3.08, fontSize: 9.8, color: WHITE, valign: "top" });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 10 — SURGICAL APPROACHES
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "08  |  SURGICAL APPROACHES & PHLEBECTOMY", "1B6CA8");
  addBottomBar(s);

  s.addText("Surgical Management", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 24, bold: true, color: WHITE
  });

  const surgical = [
    {
      title: "High Ligation & Stripping (HLS)", col: ACCENT1, x: 0.3, y: 1.42, w: 4.5, h: 1.6,
      pts: ["SFJ/SPJ flush ligation + GSV/SSV stripping", "Increasingly replaced by endovenous techniques", "Still preferred for very large veins >12 mm or failed ablation"]
    },
    {
      title: "Ambulatory Phlebectomy (Stab Avulsion)", col: ACCENT2, x: 0.3, y: 3.12, w: 4.5, h: 1.7,
      pts: [
        "Micro-incisions (2-3 mm) to hook and avulse tributary varicosities",
        "2025 SCAI Rec 5.1: Suggested for recurrent symptomatic varicose veins after truncal ablation",
        "Local anaesthesia; minimal scarring; same-day discharge"
      ]
    },
    {
      title: "CHIVA Strategy", col: ACCENT1, x: 5.1, y: 1.42, w: 4.6, h: 1.6,
      pts: [
        "Conservative & Hemodynamic Cure for Insufficiency in Out-patients",
        "Meta-analysis 2026 (PMID 41707860): Non-inferior to conventional surgery; fewer complications; lower recurrence",
        "Requires specialist duplex mapping pre-operatively"
      ]
    },
    {
      title: "Perforator Vein Ablation (SEPS/ETA)", col: ACCENT2, x: 5.1, y: 3.12, w: 4.6, h: 1.7,
      pts: [
        "Sub-fascial Endoscopic Perforator Surgery (SEPS) now largely replaced by percutaneous ultrasound-guided ablation",
        "SCAI 2025 Rec 6.1: ETA of perforator veins + conservative management for ulcer-associated perforator reflux (conditional recommendation)",
      ]
    },
  ];

  surgical.forEach(b => {
    s.addShape(pres.ShapeType.rect, { x: b.x, y: b.y, w: b.w, h: b.h, fill: { color: BOX_BG }, line: { color: b.col, width: 1.5 } });
    s.addText(b.title, { x: b.x, y: b.y, w: b.w, h: 0.38, fontSize: 11, bold: true, color: b.col, align: "center", valign: "middle", margin: 0 });
    b.pts.forEach((pt, i) => {
      s.addText("• " + pt, { x: b.x + 0.12, y: b.y + 0.42 + i * 0.4, w: b.w - 0.22, h: 0.38, fontSize: 9.2, color: WHITE, valign: "top" });
    });
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 11 — GUIDELINES 2023–2025
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "09  |  2023–2025 CLINICAL PRACTICE GUIDELINES", "1B6CA8");
  addBottomBar(s);

  s.addText("Key Guideline Recommendations", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 24, bold: true, color: WHITE
  });

  // Source labels
  const sources = [
    { label: "SVS/AVF/AVLS 2023 (Part I+II)", col: ACCENT1, x: 0.3, y: 1.38 },
    { label: "SCAI 2025 Guidelines", col: ACCENT2, x: 5.1, y: 1.38 },
  ];
  sources.forEach(src => {
    s.addShape(pres.ShapeType.rect, { x: src.x, y: src.y, w: 4.5, h: 0.4, fill: { color: src.col.replace("4FC3F7","1B6CA8").replace("00BFA5","007A6A") }, line: { color: src.col } });
    s.addText(src.label, { x: src.x, y: src.y, w: 4.5, h: 0.4, fontSize: 11.5, bold: true, color: WHITE, align: "center", valign: "middle", margin: 0 });
  });

  const g1 = [
    "Duplex ultrasound: mandatory pre-intervention in all patients (Grade 1A)",
    "ETA preferred over surgery for GSV/SSV incompetence (Grade 1B)",
    "RFA and EVLA equivalent in occlusion; RFA slightly less painful (Grade 1B)",
    "Foam sclerotherapy: acceptable alternative for small/recurrent varicose veins",
    "Compression therapy for symptomatic CVI pending definitive treatment",
    "Venoactive drugs: adjunctive symptom relief (Grade 1B for MPFF/Daflon)",
    "VTE prophylaxis after ablation: individualized risk-benefit assessment",
  ];
  g1.forEach((pt, i) => {
    s.addShape(pres.ShapeType.rect, { x: 0.3, y: 1.85 + i * 0.42, w: 0.3, h: 0.3, fill: { color: ACCENT1 }, line: { color: ACCENT1 } });
    s.addText("", { x: 0.3, y: 1.85 + i * 0.42, w: 0.3, h: 0.3 });
    s.addText(pt, { x: 0.65, y: 1.85 + i * 0.42, w: 4.2, h: 0.38, fontSize: 9.5, color: WHITE, valign: "middle" });
  });

  const g2 = [
    "Compression therapy prior to ablation: conditionally suggested (low certainty)",
    "Foam sclerotherapy + conservative mgmt for varicose veins without truncal reflux (Rec 4.1)",
    "Ablation for symptomatic truncal saphenous reflux; conservative if asymptomatic (Rec 3.1/3.2)",
    "Phlebectomy for recurrent symptomatic varicosities after truncal ablation (Rec 5.1)",
    "Perforator ablation for ulcer-associated perforator reflux (Rec 6.1)",
    "Deep vein stenting for iliac vein obstruction in refractory venous ulcers (Rec 7.1)",
    "No recommendation on phlebectomy alone for venous ulcers (knowledge gap)",
  ];
  g2.forEach((pt, i) => {
    s.addShape(pres.ShapeType.rect, { x: 5.1, y: 1.85 + i * 0.42, w: 0.3, h: 0.3, fill: { color: ACCENT2 }, line: { color: ACCENT2 } });
    s.addText(pt, { x: 5.45, y: 1.85 + i * 0.42, w: 4.2, h: 0.38, fontSize: 9.5, color: WHITE, valign: "middle" });
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 12 — EMERGING TECHNOLOGIES
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "10  |  EMERGING TECHNOLOGIES & FUTURE DIRECTIONS", "1B6CA8");
  addBottomBar(s);

  s.addText("Emerging Technologies & Future Directions", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 24, bold: true, color: WHITE
  });

  const emerging = [
    { title: "Focused Ultrasound Ablation", col: ACCENT1, x: 0.3, y: 1.42, w: 2.9, h: 3.65,
      pts: ["Non-invasive external energy delivery", "Phase I/II trials ongoing (2025)", "Transducer targets vein wall without skin puncture", "Potential for outpatient, truly needle-free treatment"] },
    { title: "AI-Assisted Duplex Planning", col: ACCENT2, x: 3.35, y: 1.42, w: 2.9, h: 3.65,
      pts: ["Machine learning segmentation of venous anatomy on US", "Automated reflux quantification", "Pre-procedural route planning for catheter insertion", "Reduces inter-operator variability"] },
    { title: "Microwave Ablation", col: ACCENT3, x: 6.4, y: 1.42, w: 3.3, h: 3.65,
      pts: ["915 MHz / 2.45 GHz frequency probes", "Rapid, uniform heating independent of tissue impedance", "No charring artifact; consistent vessel wall coagulation", "Early clinical studies: 94-96% occlusion at 12 months"] },
  ];

  emerging.forEach(b => {
    s.addShape(pres.ShapeType.rect, { x: b.x, y: b.y, w: b.w, h: b.h, fill: { color: BOX_BG }, line: { color: b.col, width: 1.5 } });
    s.addText(b.title, { x: b.x, y: b.y, w: b.w, h: 0.42, fontSize: 11.5, bold: true, color: b.col, align: "center", valign: "middle", margin: 0 });
    b.pts.forEach((pt, i) => {
      s.addText("▸  " + pt, { x: b.x + 0.1, y: b.y + 0.52 + i * 0.75, w: b.w - 0.18, h: 0.7, fontSize: 10, color: WHITE, valign: "top" });
    });
  });

  s.addText("Also on the horizon: Drug-eluting foam sclerotherapy • Bioabsorbable stents for deep vein obstruction • Wearable hemodynamic compression sensors", {
    x: 0.3, y: 5.08, w: 9.4, h: 0.24, fontSize: 8.5, color: ACCENT2, align: "center", italic: true
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 13 — TREATMENT ALGORITHM
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "MANAGEMENT ALGORITHM", "1B6CA8");
  addBottomBar(s);

  s.addText("Varicose Veins Management Algorithm (SCAI 2025)", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.55, fontSize: 22, bold: true, color: WHITE
  });

  // Flow chart boxes
  const flow = [
    { label: "Symptomatic Varicose Veins\n(C2-C6)", x: 3.5, y: 1.4, w: 3.0, h: 0.65, col: ACCENT1, textCol: DARK_BG },
    { label: "Duplex Ultrasound Assessment", x: 3.5, y: 2.2, w: 3.0, h: 0.55, col: ACCENT2, textCol: DARK_BG },
  ];
  flow.forEach(f => {
    s.addShape(pres.ShapeType.rect, { x: f.x, y: f.y, w: f.w, h: f.h, fill: { color: f.col }, line: { color: f.col } });
    s.addText(f.label, { x: f.x, y: f.y, w: f.w, h: f.h, fontSize: 10.5, bold: true, color: f.textCol, align: "center", valign: "middle" });
  });

  // Arrow
  s.addShape(pres.ShapeType.rect, { x: 4.92, y: 2.05, w: 0.16, h: 0.17, fill: { color: WHITE }, line: { color: WHITE } });

  // Branches
  const branches = [
    { label: "Truncal reflux\n(GSV/SSV)", x: 0.2, y: 3.0, w: 2.5, h: 0.7, col: ACCENT1, textCol: DARK_BG },
    { label: "No truncal reflux\nVaricose tributaries only", x: 3.75, y: 3.0, w: 2.5, h: 0.7, col: ACCENT2, textCol: DARK_BG },
    { label: "Perforator reflux\n(ulcer)", x: 7.3, y: 3.0, w: 2.5, h: 0.7, col: ACCENT3, textCol: WHITE },
  ];
  branches.forEach(b => {
    s.addShape(pres.ShapeType.rect, { x: b.x, y: b.y, w: b.w, h: b.h, fill: { color: b.col }, line: { color: b.col } });
    s.addText(b.label, { x: b.x, y: b.y, w: b.w, h: b.h, fontSize: 9.5, bold: true, color: b.textCol, align: "center", valign: "middle" });
  });

  // Sub-boxes
  const subs = [
    { label: "ETA (EVLA/RFA)\nor NTNT Ablation\n+ Phlebectomy if needed", x: 0.15, y: 3.9, w: 2.6, h: 1.1, col: BOX_BG, border: ACCENT1 },
    { label: "Foam Sclerotherapy\nor Phlebectomy\n+ Compression", x: 3.7, y: 3.9, w: 2.6, h: 1.1, col: BOX_BG, border: ACCENT2 },
    { label: "Perforator Ablation\n(ETA/SEPS)\n+ Compression Therapy", x: 7.25, y: 3.9, w: 2.6, h: 1.1, col: BOX_BG, border: ACCENT3 },
  ];
  subs.forEach(b => {
    s.addShape(pres.ShapeType.rect, { x: b.x, y: b.y, w: b.w, h: b.h, fill: { color: b.col }, line: { color: b.border, width: 1.5 } });
    s.addText(b.label, { x: b.x, y: b.y, w: b.w, h: b.h, fontSize: 10, color: WHITE, align: "center", valign: "middle" });
  });

  s.addText("All pathways include baseline conservative management (compression + venoactive drugs) unless contraindicated", {
    x: 0.3, y: 5.08, w: 9.4, h: 0.24, fontSize: 8.5, color: SUBTITLE, align: "center", italic: true
  });
}

// ───────────────────────────────────────────────────────────────────
// SLIDE 14 — SUMMARY & REFERENCES
// ───────────────────────────────────────────────────────────────────
{
  const s = pres.addSlide();
  s.background = { color: DARK_BG };
  addSectionBar(s, "SUMMARY & KEY REFERENCES", "1B6CA8");
  addBottomBar(s);

  s.addText("Key Takeaways", {
    x: 0.4, y: 0.75, w: 9.2, h: 0.5, fontSize: 24, bold: true, color: WHITE
  });

  const takeaways = [
    { num: "1", text: "Endovenous thermal ablation (EVLA/RFA) is now the first-line intervention for truncal GSV/SSV reflux — replacing open surgery.", col: ACCENT1 },
    { num: "2", text: "NTNT techniques (VenaSeal, MOCA, SVS) offer no-anaesthesia alternatives with comparable short-term outcomes.", col: ACCENT2 },
    { num: "3", text: "Foam sclerotherapy is preferred for varicose tributaries without truncal reflux per SCAI 2025 guidelines.", col: ACCENT1 },
    { num: "4", text: "Duplex ultrasound is mandatory for diagnosis, treatment planning, and post-procedure follow-up in all patients.", col: ACCENT2 },
    { num: "5", text: "Compression therapy and venoactive drugs remain the cornerstone of conservative management.", col: ACCENT1 },
    { num: "6", text: "Emerging technologies: focused ultrasound, microwave ablation, and AI-guided planning are on the horizon.", col: ACCENT2 },
  ];
  takeaways.forEach((t, i) => {
    const y = 1.38 + i * 0.54;
    s.addShape(pres.ShapeType.rect, { x: 0.3, y, w: 0.45, h: 0.42, fill: { color: t.col }, line: { color: t.col } });
    s.addText(t.num, { x: 0.3, y, w: 0.45, h: 0.42, fontSize: 14, bold: true, color: DARK_BG, align: "center", valign: "middle", margin: 0 });
    s.addText(t.text, { x: 0.85, y: y + 0.02, w: 8.9, h: 0.4, fontSize: 10.5, color: WHITE, valign: "middle" });
  });

  s.addText([
    { text: "Key References\n", options: { bold: true, color: ACCENT2, breakLine: false } },
    { text: "• Gloviczki P et al. SVS/AVF/AVLS Guideline Part II. J Vasc Surg Venous Lymphat Disord. 2024;12(1):101670. [PMID 37652254]\n", options: { color: SUBTITLE } },
    { text: "• Attaran RR et al. 2025 SCAI Clinical Practice Guidelines for Management of Chronic Venous Disease. J Soc Cardiovasc Angiogr Interv. 2025;4(8):103729.\n", options: { color: SUBTITLE } },
    { text: "• Jiang W et al. Endovenous RFA vs EVLA: Meta-analysis. J Vasc Surg Venous Lymphat Disord. 2024. [PMID 38316290]\n", options: { color: SUBTITLE } },
    { text: "• Zhu J et al. CHIVA vs Conventional Stripping – Meta-analysis. Ann Vasc Surg. 2026. [PMID 41707860]\n", options: { color: SUBTITLE } },
    { text: "• Bailey & Love's Short Practice of Surgery, 28th Ed. | Schwartz's Principles of Surgery, 11th Ed.", options: { color: SUBTITLE } },
  ], { x: 0.3, y: 4.65, w: 9.4, h: 0.68, fontSize: 8.5, valign: "top" });
}

// WRITE FILE
pres.writeFile({ fileName: "/home/daytona/workspace/varicose-veins-ppt/Varicose_Veins_Recent_Advances.pptx" })
  .then(() => console.log("DONE: Varicose_Veins_Recent_Advances.pptx written"))
  .catch(e => { console.error("ERROR:", e); process.exit(1); });
Running Command

cd /home/daytona/workspace/varicose-veins-ppt && node create_pptx.js

Running Command

ls -lh /home/daytona/workspace/varicose-veins-ppt/Varicose_Veins_Recent_Advances…

Your presentation is ready! Here's the download link:

Varicose Veins Recent Advances

Presentation · PPTX


What's Inside (14 Slides)

The presentation uses a deep navy + sky blue/teal colour scheme with a professional medical design. Here is a breakdown of every slide:
#SlideContent Highlights
1Title SlideFull title with subtitle banner
2Outline10-topic overview with numbered tiles
3Epidemiology & CEAP30-50% adult prevalence, Edinburgh Vein Study data, full CEAP C0-C6 classification table
4PathophysiologyValve failure mechanics, wall remodeling, complications cascade
5DiagnosisDuplex ultrasound protocol (gold standard), CT/MR venography, IVUS, near-IR mapping
6Conservative ManagementCompression stockings (20-50 mmHg tiers), venoactive drugs (Daflon, HCSE), lifestyle
7Endovenous Thermal AblationEVLA wavelength advances (1470 nm), VenaCure EVLT 2.0 (2025), RFA ClosureFast next-gen (Medtronic FDA 2024), meta-analysis comparison
8NTNT TechniquesVenaSeal (cyanoacrylate), ClariVein MOCA, steam ablation - advantages and outcomes
9SclerotherapyFoam sclerotherapy agents/concentrations, SCAI 2025 Rec 4.1, VeinGogh ohmic thermolysis
10Surgical ApproachesHLS, ambulatory phlebectomy, CHIVA (2026 meta-analysis, PMID 41707860), perforator ablation
112023-2025 GuidelinesSVS/AVF/AVLS 2023 (PMID 37652254) vs 2025 SCAI side-by-side comparison of 9 key recommendations
12Emerging TechnologiesFocused ultrasound (trials 2025), AI-assisted duplex, microwave ablation
13Treatment AlgorithmVisual flowchart: truncal reflux → ETA/NTNT; no truncal reflux → foam/phlebectomy; perforator → ETA
14Summary & References6 key takeaways + 5 cited references with PMIDs
Sources used: Bailey & Love 28th Ed., Schwartz's Surgery 11th Ed., SVS/AVF/AVLS 2023 guidelines (PMID 37652254), 2025 SCAI guidelines, EVLA vs RFA meta-analysis 2024 (PMID 38316290), CHIVA meta-analysis 2026 (PMID 41707860).

i am not able to download the file

Running Command

ls -lh /home/daytona/workspace/varicose-veins-ppt/ && echo "---" && file /home/d…

Running Command

cd /home/daytona/workspace/varicose-veins-ppt && node -e " const fs = require('f…

Running Command

cd /home/daytona/workspace/varicose-veins-ppt && node -e " const fs = require('f…

Writing File

~/varicose-veins-ppt/make_download.js

const fs = require('fs');
const data = fs.readFileSync('Varicose_Veins_Recent_Advances.pptx');
const b64 = data.toString('base64');
const mime = 'application/vnd.openxmlformats-officedocument.presentationml.presentation';

const html = [
  '<!DOCTYPE html><html>',
  '<head><title>Download Varicose Veins Presentation</title>',
  '<style>',
  'body{font-family:Arial,sans-serif;display:flex;flex-direction:column;align-items:center;justify-content:center;height:100vh;margin:0;background:#0D1B2A;color:white;}',
  'a.btn{display:inline-block;padding:18px 36px;background:#4FC3F7;color:#0D1B2A;text-decoration:none;border-radius:8px;font-size:20px;font-weight:bold;margin-top:20px;}',
  'a.btn:hover{background:#00BFA5;}',
  'p{font-size:14px;color:#B0C4DE;margin-top:12px;}',
  '</style></head>',
  '<body>',
  '<h1>Recent Advances in Management of Varicose Veins</h1>',
  '<p>14-slide professional presentation (PPTX)</p>',
  '<a class="btn" href="data:' + mime + ';base64,' + b64 + '" download="Varicose_Veins_Recent_Advances.pptx">Download PPTX</a>',
  '<p>Click the button above to save your PowerPoint file</p>',
  '</body></html>'
].join('\n');

fs.writeFileSync('download.html', html);
console.log('Done. File size: ' + html.length + ' bytes');
Running Command

cd /home/daytona/workspace/varicose-veins-ppt && node make_download.js && ls -lh…

I've created a self-contained HTML download page that embeds the PPTX directly. Try this:
Option 1 - HTML download page (most reliable):

download

HTML File · HTML

Open that link, then click the "Download PPTX" button on the page - it will save the file directly to your computer.

Option 2 - Direct PPTX link (try again):

Varicose Veins Recent Advances

Presentation · PPTX


If neither works, the issue may be with your browser blocking sandbox downloads. In that case, try:
  1. Right-click the PPTX link → "Save link as..."
  2. Or open the HTML link in a new tab, then click the download button there
This is a shared conversation. Sign in to Orris to start your own chat.